Supplementary Table S7 from A First-in-Human Phase I Clinical Trial Evaluating Clinical Activity and Proof of Mechanism of Tobemstomig, a PD-1–LAG-3 Bispecific Antibody, in Patients with CPI-Experienced Melanoma
Authors:
- Elena GarraldaEGElena Garralda
- Christoph MarkertCMChristoph Markert
- Victor MorenoVictor Moreno
- Emiliano CalvoECEmiliano Calvo
- Kristoffer RohrbergKRKristoffer Rohrberg
- Tae Min KimTKTae Min Kim
- Dae Ho LeeDLDae Ho Lee
- Jonathan E. CohenJCJonathan E. Cohen
- Darren W.T. LimDLDarren W.T. Lim
- Fiona C. ThistlethwaiteFTFiona C. Thistlethwaite
- Byoung Chul ChoBCByoung Chul Cho
- Yu Jung KimYKYu Jung Kim
Open Access
- 1 July 2026
- other
- Published by American Association for Cancer Research (AACR)